GTX Inc. (GTXI) was a big mover last session, as its shares rose over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 7, as the stock is now trading above the volatile price range of $1.32 to $1.50.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
GTX currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Better-ranked stocks in the medical sector include TrovaGene, Inc. (TROV), ZIOPHARM Oncology, Inc. (ZIOP) and Regeneron Pharmaceuticals, Inc. (REGN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
REGENERON PHARMACEUTICAL INC (REGN): Free Stock Analysis Report
TROVAGENE NEW (TROV): Free Stock Analysis Report
GTX INC (GTXI): Free Stock Analysis Report
ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading
- GTX Inc.